PhD Urša Pečar Fonović

PhD Urša Pečar Fonović
no.: 19170 source: ARIS

researcher – active in research organisation
(01) 476 95 00
  ursa.pecarfonovicat signffa.uni-lj.si
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • Serbo-Croatian (Roman)
  • Reading: Fluent
  • Writing: Basic
  • Speaking: Functional
  • German
  • Reading: Functional
  • Writing: Functional
  • Speaking: Functional
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Keywords
cancer, proteases, cathepsins, biochemistry, biotechnology
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
260.2
A''
52.79
A'
146.46
A1/2
192.04
CI10
695
CImax
104
h10
14
A1
0.96
A3
0
Data for the last 5 years (citations for the last 10 years) on May 14, 2026; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 34  976  838  24.65 
Scopus 34  1,052  907  26.68 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.   Molecular Biology  SI University of Ljubljana, Biotechnical Faculty 1997 
Master's degree  M. Sc.   Biochemistry and Molecular Biology  SI University of Ljubljana, Faculty of Medicine 2000 
Doctoral degree  Ph. D.     SI University of Ljubljana, Faculty of Medicine 2015 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  10/1/2007  Assistant  Researcher  Assistant professor 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J1-70052  Light-Driven Expansion of Chemical Space for Challenging Targets (LUX: BLI-AS-MS)   3/1/2026 - 2/28/2029  PhD Janez Ilaš   1,742 
2. J1-70042  Neuroprotective and regenerative activity of γ-enolase as new therapeutic strategy in neuroinflammation-induced neurodegeneration   3/1/2026 - 2/28/2029  PhD Anja Pišlar   3,035 
3. J1-70043  Preclinical development of mitochondrial chaperone TRAP1 inhibitors as anticancer agents   3/1/2026 - 2/28/2029  PhD Tihomir Tomašić   1,268 
4. J3-60067  Cathepsin Targeted Immunotherapy for Pancreatic Cancer Treatment -CATIMMPACT   1/1/2025 - 12/31/2027  PhD Milica Perišić Nanut   2,361 
5. J3-60060  Extracellular vesicles from recombinant Lactococcus lactis as novel protein delivery vectors for treatment of intestinal inflammation and prevention of colorectal cancer   1/1/2025 - 12/31/2027  PhD Tina Vida Plavec   1,300 
6. J3-50099  A novel therapeutic strategy for allergic diseases based on epitope-paratope blocking   10/1/2023 - 9/30/2026  PhD Peter Korošec   1,851 
7. J3-3071  Cathepsins B and X in breast cancer stem cells – molecular targets and relevance for antitumor therapy   10/1/2021 - 3/31/2025  PhD Ana Mitrović   2,929 
8. J1-2484  Development of antibacterial compounds targeting validated enzymes in peptidoglycan biosynthesis   9/1/2020 - 8/31/2023  PhD Stanislav Gobec   4,308 
9. J4-1776  Improvement of immunotherapeutic potential of NK cells through modulation of cystatin F   7/1/2019 - 6/30/2022  PhD Janko Kos   3,421 
10. J3-9267  Inhibition of cathepsin X activity as a novel strategy for the treatment of Parkinson's disease   7/1/2018 - 6/30/2021  PhD Anja Pišlar   3,096 
11. J4-8227  Preprečevanje rezistence tumorskih celic na antiproteazno terapijo z inhibitorji katepsina X. (Slovene)   5/1/2017 - 4/30/2020  PhD Janko Kos   5,281 
12. J4-6811  Vloga inhibitorjev cisteinskih proteaz v citotoksičnem delovanju naravnih celic ubijalk na tumorske celice (Slovene)   7/1/2014 - 6/30/2017  PhD Janko Kos   2,889 
13. J4-5529  Nitroksolin in njegovi derivati kot nova protitumorska zdravila (Slovene)   8/1/2013 - 7/31/2016  PhD Janko Kos   6,812 
14. J4-4123  Inhibitorji cisteinskih karboksipeptidaz kot regulatorji avtoimunskih in nevrodegenerativnih procesov (Slovene)   7/1/2011 - 6/30/2014  PhD Janko Kos   7,112 
15. J3-0488  FUNKCIONALNA ANALIZA NEKODIRAJOČIH RNA PRI PARKINSONOVI BOLEZNI (Slovene)   2/1/2008 - 1/31/2011  PhD Boris Rogelj   2,526 
16. L3-0129  IZVENCELIČNE NUKLEINSKE KISLINE V DIAGNOSTIKI KORONARNE ATEROSKLEROZE (Slovene)   2/1/2008 - 1/31/2011  PhD Darko Černe   2,152 
17. L4-1046  Nove zdravilne učinkovine biotehnološkega izvora z uporabo bakteriofagnega prikaza (Slovene)   2/1/2008 - 1/31/2011  PhD Borut Štrukelj   4,447 
18. J4-9425  Lektini kot modulatorji protitumorskega imunskega odziva (Slovene)   1/1/2007 - 12/31/2009  PhD Janko Kos   2,417 
19. V4-0760  Karakterizacija populacij gliv iz rodu Phytophthora kot podlaga za izboljšanje metod prognostike in varstva (Slovene)   10/1/2002 - 9/30/2006  PhD Alenka Munda   2,600 
20. V4-0461  Postopki nadziranja in diagnosticiranja nekaterih nevarnih škodljivih organizmov ter študij populacij na različnih geografskih območjih (Slovene)   1/1/2002 - 10/31/2005  PhD Gregor Urek   4,598 
21. J4-7421  Obrambni proteini v rastlinskih celicah (Slovene)   1/1/1996 - 6/30/2001  PhD Borut Štrukelj   5,061 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P4-0127  Pharmaceutical biotechnology: Science for health   1/1/2019 - 12/31/2027 PhD Anja Pišlar   5,909 
2. P4-0127  Pharmaceutical biotechnology: Science for Health   1/1/2015 - 12/31/2018 PhD Janko Kos   5,560 
3. P4-0127  Pharmaceutical biotechnology: Knowledge for Health   1/1/2004 - 12/31/2008 PhD Janko Kos   5,843 
Confirmation required
Views history
Favourite